IMAC Holdings, Inc. Announces Opening Enrollment in Its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
05 nov. 2020 09h00 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn, Nov. 05, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings, Inc. Adds Three Distinguished Executives to its Board of Directors
02 nov. 2020 09h25 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Nov. 02, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings, Inc. Partners with Safe Balance, LLC to Provide Services that Improve Balance for the Reduction of Fall Risk
23 sept. 2020 09h15 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn and BIRMINGHAM, Mich., Sept. 23, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings Announces Update to Service Locations
15 sept. 2020 09h25 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Sept. 15, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic...
IMAC Holdings to Present at the LD Micro 500 Virtual Conference on September 1, 2020
25 août 2020 08h30 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Aug. 25, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings Reports Second Quarter 2020 Financial Results
14 août 2020 09h00 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Aug. 14, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care, specializing in regenerative...
IMAC Holdings Receives FDA Authorization to Initiate Clinical Study of Its Umbilical Cord-Derived Allogenic Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
05 août 2020 11h58 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Aug. 05, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Regeneration Centers Sells Lexington Property for $1.3M in Sale-Leaseback Transaction
27 juil. 2020 10h30 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., July 27, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings Prices $2.65 Million Common Stock Offering
18 juin 2020 08h45 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., June 18, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic...
IMAC Regeneration Centers Analysis Shows 81% of Patients Report Improvement in Functional Outcomes from Treatment of Musculoskeletal Conditions
17 juin 2020 08h00 HE
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., June 17, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic...